Subscribe What is EndoPredict? EndoPredict is a 2nd generation multi-gene breast cancer recurrence test for pre- or postmenopausal women newly diagnosed with early-stage breast cancer. Created for the purpose of highly accurate assessment of 5 to year risk of distant recurrence of the disease EndoPredict combines into an unique indicator EPClin score gene expression with clinically pathological features providing outstanding prognostic performance that will ensure the healthcare professional that chemotherapy is or is not required to accompany endocrine treatment. Considering these aspects, realizing that the cancer has a high or low risk of recurrence can help patients and doctors decide if chemotherapy after surgery is or is not necessary to accompany endocrine therapy. What DNA sample is required to perform the test?
Institute of Oncology Prof. Alexandru Trestioreanu History The centre was founded over 60 cancer endocrine therapies ago.
Radiotherapy RT is an important cancer endocrine therapies for breast cancer, but sometimes there is a minimal locoregional benefit for some patients and no survival benefit for others. Radiotherapists should take into consideration to minimize infectious risk without compromising oncologic outcomes. Radiotherapist should take into consideration omitting RT whenever appropriate, delaying or abbreviating RT whenever appropriate. Omit RT for patients 65 years old and over or younger, with relevant comorbidities, with invasive breast cancer that are up to 30 mm with clear margins, Goestrogen receptor [ER] positive, human epidermal growth factor receptor 2 [HER2] negative and node negative, who are planned for treatment with endocrine therapy
Currently it comprises 4 surgical wards, 3 radiotherapy wards, 2 wards of medical oncology, 1 department of paediatric oncology. In total there are beds.
After three years we considered that the ESMO requirements were not covered properly by our centre and did not apply for re-accreditation in After making efforts and improving certain areas of care, in the Institute of Oncology Bucharest applied and was accepted again to be designated as an ESMO Designated Centre. The department has 4 dedicated beds for palliative care, but will shortly increase to The centre collaborates with 2 institutions who offer palliative care and support at home.
Doctors and nurses working on our ward participate in clinical trials and courses regarding palliation. Profile The Medical Oncology and Palliative Care Department performs chemotherapy for solid tumours and hematologic malignancy it also provides palliative and supportive care for patients with early and advance stages of cancer.
Specialities Cancer endocrine therapies department provides chemotherapy for early stages of cancer and chemotherapy and bio-therapy for advanced cancer. There is a partnership with the departments of surgery and radiotherapy for determining the needs for palliative care. We have stadiul invaziv al diphildobothriasisului collaboration with the intensive care service for cases requiring resuscitation and to decide when the patient can no longer benefit from active treatment against cancer.
Supportive and Palliative Medicine.